Background
==========

Left ventricular late gadolinium enhancement (LV-LGE) is a known incidental cardiac magnetic resonance (CMR) finding in atrial fibrillation (AF) patients and has recently been associated with increased mortality \[[@B1]\]. While LV-LGE is an indicator of poor prognosis in patients with cardiomyopathy, data on the clinical significance of incidental findings of LV-LGE in AF patients is still unavailable. We aimed to evaluate the association of this incidental finding to ischemic stroke in atrial fibrillation.

Methods
=======

A 1:2 observational case-control study was conducted with a dataset of cases with new onset ischemic stroke after 1st CMR scan and controls matched by age and sex. Cases and controls were selected from a database of 762 AF patients without any prior history of MI who underwent cardiac MRI exams between June 2006 and January 2013. We manually reviewed the electronic medical records of all patients with CMR and sequentially selected the first identified age and sex matched controls (subjects without stroke event after their CMR scan). Two experienced readers scrutinized the CMR scans of cases and controls for presence of left ventricular delayed enhancement. We then collected all comorbidities and conducted univariate (Chi-square test/t-test as appropriate) and multivariate analyses to examine the association between LV-LGE and occurrence of stroke.

Results
=======

Out of 762 patients, we identified 14 cases (1.8%) with new onset ischemic stroke after the first MRI scan. Of these cases, 2 (14%) were found to have LV-LGE. We age and sex matched these 14 cases with 28 controls in a 1:2 fashion. Description of demographic variables and univariate measures of association are presented in Table [1](#T1){ref-type="table"}. Prior stroke and use of calcium channel and beta blockers were the only statistically significant differences between the two groups. We found a statistically significant association between LV-LGE and occurrence of stroke (McNemar\'s Chi square test, P = 0.0034). In a conditional logistic regression model, LV-LGE predicted the occurrence of stroke perfectly. After accounting for LV-LGE, CHADS2 score was the only variable that predicted the occurrence of stroke in AF patients (odds ratio = 2.05, 95% CI = 1.01 - 4.16, P = 0.045). The presence of LV-LGE incrementally predicts stroke risk with higher CHADS2 score Table [2](#T2){ref-type="table"}.

###### 

Demographics

                                 Ischemic stroke after CMR scan   No stroke       P value
  ------------------------------ -------------------------------- --------------- ---------
  Sex                            6 females                        12 females      1.00
                                                                                  
  Age                            67.47 ± 12.16                    67.50 ± 9.00    0.99
                                                                                  
  DM                             2                                3               0.7
                                                                                  
  HTN                            8                                17              0.8
                                                                                  
  CHF                            3                                3               0.35
                                                                                  
  Prior Stroke                   4                                1               0.018
                                                                                  
  Dyslipidemia                   6                                6               0.147
                                                                                  
  Obstructive sleep apnea        1                                4               0.5
                                                                                  
  Thyroid disease                3                                7               0.79
                                                                                  
  Smoking history                4                                7               0.804
                                                                                  
  Class I antiarrythmic drug     2                                2               0.45
                                                                                  
  Class III antiarrythmic drug   2                                4               1.00
                                                                                  
  Anticoagulants                 9                                12              0.19
                                                                                  
  ASA                            3                                9               0.46
                                                                                  
  Statins                        5                                6               0.32
                                                                                  
  Calcium channel blocker        1                                12              0.018
                                                                                  
  Beta blocker                   9                                7               0.013
                                                                                  
  ACEI/ARBs                      7                                12              0.661
                                                                                  
  Diuretics                      7                                7               0.105
                                                                                  
  GFR                            72.64 ± 21.04                    75.28 ± 23.12   0.72
                                                                                  
  LV end diastolic diameter      4.87 ± 1.03                      4.93 ± 0.69     0.82
                                                                                  
  LA area                        29.67 ± 1.66                     30.78 ± 7.55    0.636
                                                                                  
  BMI                            27.22 ± 7.82                     30.79 ± 6.12    0.112

###### 

Delta Method margins show LV-LGE as an incremental predictor of stroke after first CMR scan in AF patients based on CHADS2 score

  CHADS2 Score   Margin   Standard Error   P value   95% CI
  -------------- -------- ---------------- --------- --------------
  0              0.111    0.105            0.289     -0.094-0.316
                                                     
  1              0.313    0.116            0.007     0.085-0.540
                                                     
  2              0.400    0.155            0.010     0.096-0.704
                                                     
  3              0.571    0.187            0.002     0.205-0.938

Conclusions
===========

In this case-control study of AF patients without a history of MI, an incidental finding of LV-LGE is shown to predict the risk of stroke, especially in the case of patients with a higher CHADS2 score.
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